Literature DB >> 18617619

Interleukin-1 mediates the anorexic and febrile actions of galanin-like Peptide.

Pui-Sin Man1, Catherine B Lawrence.   

Abstract

Galanin-like peptide (GALP) is a neuropeptide that has complex actions on energy balance, producing orexigenic effects in the short term in rats but anorexigenic and febrile effects over the longer term in rats and mice. GALP is thought to promote feeding via neuropeptide Y and orexin neurons, but the mediators of the anorexia are unknown. However, the anorexic and febrile actions of GALP are similar in magnitude and profile to those seen after central injections of the cytokine IL-1. Thus, the aim of this study was to test the hypothesis that IL-1 mediates the effects of GALP on energy balance. Intracerebroventricular injection of GALP (1.5 nmol) in male Sprague-Dawley rats stimulated production of IL-1alpha and IL-1beta protein in macrophages and/or microglia in selected brain areas, including the meninges, and periventricular brain regions. Intracerebroventricular injection of GALP in rats stimulated food intake over 1 h but decreased feeding and body weight at 24 h and caused a rise in core body temperature over 8 h. Coinfusion of the IL-1 receptor antagonist had no effect on the GALP-induced orexigenic response but significantly reduced the longer-term actions of GALP observed at 24 h and its effect on body temperature. Furthermore, the actions of GALP on feeding, body weight, and body temperature were significantly reduced in IL-1alpha/beta-, IL-1beta-, or IL-1 type I receptor (IL-1RI)-deficient mice. These data suggest that GALP induces expression of IL-1 in the brain, and its anorexic and febrile actions are mediated by this cytokine acting via IL-1 type I receptor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617619      PMCID: PMC3306896          DOI: 10.1210/en.2008-0252

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  38 in total

Review 1.  TLR4 as the mammalian endotoxin sensor.

Authors:  B Beutler
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

2.  Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor.

Authors:  Omar Touzani; Herve Boutin; Rosalind LeFeuvre; Lisa Parker; Andy Miller; Giamal Luheshi; Nancy Rothwell
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

3.  Distribution and regulation of galanin-like peptide (GALP) in the hypothalamus of the mouse.

Authors:  A Juréus; M J Cunningham; D Li; L L Johnson; S M Krasnow; D N Teklemichael; D K Clifton; R A Steiner
Journal:  Endocrinology       Date:  2001-12       Impact factor: 4.736

4.  Anorexic but not pyrogenic actions of interleukin-1 are modulated by central melanocortin-3/4 receptors in the rat.

Authors:  C B Lawrence; N J Rothwell
Journal:  J Neuroendocrinol       Date:  2001-06       Impact factor: 3.627

5.  Stimulation effect of galanin-like peptide (GALP) on luteinizing hormone-releasing hormone-mediated luteinizing hormone (LH) secretion in male rats.

Authors:  H Matsumoto; J Noguchi; Y Takatsu; Y Horikoshi; S Kumano; T Ohtaki; C Kitada; T Itoh; H Onda; O Nishimura; M Fujino
Journal:  Endocrinology       Date:  2001-08       Impact factor: 4.736

6.  Galanin-like peptide stimulates food intake in the rat.

Authors:  Yoshio Matsumoto; Takuya Watanabe; Yuka Adachi; Takashi Itoh; Tetsuya Ohtaki; Haruo Onda; Tsutomu Kurokawa; Osamu Nishimura; Masahiko Fujino
Journal:  Neurosci Lett       Date:  2002-03-29       Impact factor: 3.046

7.  A role for galanin-like peptide in the integration of feeding, body weight regulation, and reproduction in the mouse.

Authors:  Stephanie M Krasnow; Gregory S Fraley; Sonya M Schuh; James W Baumgartner; Donald K Clifton; Robert A Steiner
Journal:  Endocrinology       Date:  2003-03       Impact factor: 4.736

8.  Changes in hypothalamic expression levels of galanin-like peptide in rat and mouse models support that it is a leptin-target peptide.

Authors:  Satoshi Kumano; Hirokazu Matsumoto; Yoshihiro Takatsu; Jiro Noguchi; Chieko Kitada; Tetsuya Ohtaki
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

9.  Differential patterns of Fos induction in the hypothalamus of the rat following central injections of galanin-like peptide and galanin.

Authors:  Gregory S Fraley; Issei Shimada; James W Baumgartner; Donald K Clifton; Robert A Steiner
Journal:  Endocrinology       Date:  2003-04       Impact factor: 4.736

10.  Centrally administered galanin-like peptide modifies food intake in the rat: a comparison with galanin.

Authors:  C B Lawrence; F M-H Baudoin; S M Luckman
Journal:  J Neuroendocrinol       Date:  2002-11       Impact factor: 3.627

View more
  5 in total

Review 1.  Galanin-like peptide (GALP) is a hypothalamic regulator of energy homeostasis and reproduction.

Authors:  Catherine Lawrence; Gregory S Fraley
Journal:  Front Neuroendocrinol       Date:  2010-06-15       Impact factor: 8.606

2.  Galanin-like peptide (GALP) facilitates thermogenesis via synthesis of prostaglandin E2 by astrocytes in the periventricular zone of the third ventricle.

Authors:  Haruaki Kageyama; Kei Endo; Toshimasa Osaka; Jun Watanabe; Li Hua Wang; Kazuo Ito; Mamiko Suzuki; Junichi Sakagami; Fumiko Takenoya; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2013-01-26       Impact factor: 3.444

3.  Galanin receptors and ligands.

Authors:  Kristin E B Webling; Johan Runesson; Tamas Bartfai; Ulo Langel
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-07       Impact factor: 5.555

4.  Thermoregulatory effect of alarin, a new member of the galanin peptide family.

Authors:  Alexandra Mikó; Péter Balla; Judit Tenk; Márta Balaskó; Szilvia Soós; Miklós Székely; Susanne Brunner; Barbara Kofler; Erika Pétervári
Journal:  Temperature (Austin)       Date:  2014-07-02

5.  Anti-obesity effect of intranasal administration of galanin-like peptide (GALP) in obese mice.

Authors:  Haruaki Kageyama; Kanako Shiba; Satoshi Hirako; Nobuhiro Wada; Satoru Yamanaka; Yukinori Nogi; Fumiko Takenoya; Naoko Nonaka; Tsutomu Hirano; Shuji Inoue; Seiji Shioda
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.